Peptide News Digest

#Topical

2 stories

Research · View digest

BMC Biotechnology: DualPep-ALO Synthetic Cell-Penetrating Peptide Promotes Hair Growth via Anti-Inflammatory + Pro-Regenerative Pathways in Preclinical Models

A 2026 BMC Biotechnology paper introduces DualPep-ALO, a novel synthetic cell-penetrating peptide engineered to promote hair growth by restoring the follicular microenvironment and stimulating regenerative pathways. In preclinical models, DualPep-ALO showed potent antioxidant, anti-inflammatory, and pro-regenerative effects, restoring follicular vitality through multimodal biological pathways. The paper supports the peptide's potential as a topical CPP-based agent for hair loss, warranting further clinical investigation. The work joins a 2026 wave of peptide-led hair-growth research alongside copper-peptide GHK-Cu's surge in the cosmetic and longevity-clinic space and the broader 'peptide therapy' search trend that Drexel's May 5 Q&A flagged as a 1,016% YoY rise for GHK-Cu specifically.

Industry · View digest

Neurogan Health Launches 2% GHK-Cu Copper Peptide Body Care After 12-Week Clinical Trial Showing 32.8% Wrinkle Depth Reduction and 20–30% Skin Firmness Improvement

Neurogan Health expanded its product line with a topical 2% GHK-Cu copper peptide body care, supported by a 12-week clinical trial reporting 32.8% reduction in wrinkle depth and 20–30% improvement in skin firmness. The launch lands in a 2026 GHK-Cu market characterized by surging consumer interest — the peptide is the fastest-growing skincare ingredient by search volume, with patient interest spanning skin rejuvenation, hair loss, and systemic longevity. Topical GHK-Cu has the strongest evidence base among research peptides, going back decades on wound healing and collagen synthesis, and topical applications avoid the regulatory gray zone around the injectable formulation.